Zylox-Tonbridge Medical Technology , Ltd. Receivables

The latest receivables for 2190.HK is $91M as of June 2026. That compares with $2.4M in the prior-year period — up 3729.4% year over year. Investors often review this figure alongside Zylox-Tonbridge Medical Technology , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 2190.HK's receivables moved from $2.4M to $91M — a 3729.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zylox-Tonbridge Medical Technology , Ltd.'s operating scale or balance-sheet position.

A receivables figure of $91M for 2190.HK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 2190.HK's receivables ($91M), review year-over-year change from $2.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.